Solubility: Soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml)
Appearance: Off-white solid
PubChem CID: 25126798
Scientific Background: Ruxolitinib is a Janus-associated kinases (JAK) inhibitor, which specifically inhibits JAK1 and JAK3. JAKs are known to active the signaling of certain growth factor receptors and cytokines.